94 results
Page 3 of 5
8-K
EX-10.1
21duwqq bv6pcvq
2 May 22
Departure of Directors or Certain Officers
4:07pm
8-K
EX-10.2
4ajywzpxrxwobqy
2 May 22
Departure of Directors or Certain Officers
4:07pm
8-K
EX-99.1
h0dr4exv qnbymz1ca
8 Mar 22
Magenta Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Highlights
8:26am
8-K
EX-99.1
bfl6efzuo6t23 ux4
10 Jan 22
Magenta Therapeutics Highlights Recent Pipeline Progress and Milestone Expectations for 2022
8:15am
8-K
EX-99.1
kzuil 83dm2rj
11 Jan 21
Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical Trials
8:16am
424B5
fr8462c90jaybtmfc1q0
25 Jun 20
Prospectus supplement for primary offering
5:11pm
424B5
n51 3vjbcotj45xwih2
24 Jun 20
Prospectus supplement for primary offering
5:29pm